title: [Position paper about isotretinoin on acne vulgaris].
abstract: Isotretinoin was authorized since 1982 for the treatment of acne vulgaris associated to severe cutaneous lesions. It has been used in others clinical conditions in various plans of prescription. Since the Isotretinoin was launched, it caused controversies in our country and around the world, especially in relation with the security. Isotretinoin is proscribed in pregnant patient. As a security rule we must measure serum lipids and hepatic enzymes. The aim of the consensus was to spread information worked by a group of Mexican experienced dermatologists to the health professionals about the use and the specific indications about isotretinoin.
authors.affiliation: Servicio de Dermatología, Hospital Universitario José Eleuterio González, Monterrey, Nuevo León, México. minervagomezmx@yahoo.com.mx
authors.forename: Minerva
authors.initials: M
authors.lastname: Gómez-Flores
authors.forename: Linda
authors.initials: L
authors.lastname: García-Hidalgo
authors.forename: Leonel
authors.initials: L
authors.lastname: Fierro-Arias
authors.forename: Javier
authors.initials: J
authors.lastname: Ruiz-Ávila
authors.forename: Maira
authors.initials: M
authors.lastname: Herz-Ruelas
authors.forename: Jorge
authors.initials: J
authors.lastname: Garza-Gómez
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
chemical_list: D015474:Isotretinoin